Bromazépam Viatris 6 mg

Bromazépam Viatris is a generic pharmaceutical product used for the treatment of severe anxiety. It belongs to the benzodiazepine class of medications. This specific packaging is marketed for the French domestic market.

The Viatris brand was formed through a major corporate merger in late 2020. The company operates numerous manufacturing sites globally, but for products specifically labeled for the French market, production often occurs in France (such as at their site in Mérignac or Meyzieu) or within the European Union to ensure stable supply chains and regulatory compliance.